Mavelertinib
Mavelertinib (PF-06747775) is a potent, orally bioavailable, and selective EGFR tyrosine kinase inhibitor targeting oncogenic mutants including T790M/L858R and T790M/Del. It is a research tool for investigating non-small cell lung cancer (NSCLC), with demonstrated activity in both cellular assays and in vivo xenograft models.
Product Specifications
CAS Number
1776112-90-3
Product Name Alternative
PFE-X775, PF6747775, PF-6747775, PF-7775, PF06747775, PF-06747775, PF 6747775, PF 06747775, EGFR (T790M/L858R), Mavelertinib
Field of Research
Cardiovascular Research, Signal Transduction
Purity
99.89% (May vary between batches)
Solubility
H2O:<0.1 mg/mL; DMSO:30 mg/mL (72.22 mM)
Smiles
COc1nn (C) cc1Nc1nc (nc2n (C) cnc12) N1C[C@@H] (F) [C@@H] (C1) NC (=O) C=C
Molecular Formula
C18H22FN9O2
Molecular Weight
415.42
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
23831124 3x 1.0µg DNA
HOXC11 CRISPRa sgRNA lentivector (set of three targets)(Mouse)
Sign In for Pricing
View Details 
